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Abstract  
The aim of the present study is to evaluate the levels of visfatin in sera of non-diabetic male with 
hyperlipidemia classified according to Frederickson classification  .At the same time to find the correlation of 
visfatin with related parameters in the studied groups. The study included (22) healthy Iraqi male as control 
group (G1) and (62) non-diabetic male diagnosed with hyperlipidemia which divided into three groups as 
follows: group(2)consist of (20)male with hypercholesterolemia[Type I] ,group (3)consist of (20) male with 
hypertriglyceridemia [Type IIa] and group (4):consist of (22)male with hypercholesterolemia and 
hypertriglyceridemia [Type IIb] .The age of all studied groups ranged between (21-50) years and BMI with 
(19.8-24.3) Kg/m2 .Serum was used for determination of FBG, lipid profile(HDL,LDL,VLDL,TG) ,insulin ,CRP 
and visfatin .Whole  blood was used for determination of  HbA1C. The results revealed  no significant elevation 
in FBS and HbA1C levels were seen in patients groups when comparing to healthy control . The results indicates 
a significant elevation in TC and LDL in G2and G4 comparing to G1. Also, there are significant elevation in G3 
comparing to G 2 and G4 comparing to G3,while no significant elevation was found in TC and VLDL in G3 
with G1and G4 with G2.The results ,also, illustrated significant elevation in TG and VLDL in G3 and G4 when 
comparing to G1, and in G3,G4 comparing to G2 . No significant elevation was noticed in G2 comparing to 
G1and G4 comparing to G3 . HDL levels showed significant decrease in G2,G3 and G4 comparing to G1. No 
significant decrease seen in G3 and G4 comparing to G2 and in G4 comparing to G3.A high significant elevation 
in insulin and HOMA-IR levels in G2,G3 and G4 was found when comparing with G1 , while a significant 
elevation  was noticed in G3 and G4 when comparing with G2 and in G4 when comparing with G3. The  results, 
also ,showed significant increase  in CRP  and visfatin levels for  G2,G3 ,G4 when comparing to G1  and in G4 
when comparing to G2 and  G3 . But no significant elevation was found in G3 when comparing to G2 .A 
significant positive correlation was found between visfatin levels and TC in G1,G2 and G4 while significant 
negative correlation was observed in G3 between visfatin and TC. A high significant positive correlation 
coefficients was found between visfatin and TG in four studied groups .The results , also, showed a significant 
negative correlation between visfatin levels and HDL for all studied groups .The results  illustrated significant 
positive correlation in visfatin levels with LDL in G1 and G4 while there are significant negative correlation in 
visfatin levels with LDL in G2 and G3. A significant negative correlation between visfatin and insulin ,HOMA-
IR levels was noticed in all studied groups. 
The conclusion could be drown from this study that visfatin increased in  G4 more than other groups 
comparing to G1 . Also, there are significant correlation between visfatin levels with insulin , HOMA-IR and 
CRP levels. 
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Introduction 
 Lipoproteins are substances made of cholesterol ,triglycerides ,and proteins . They move cholesterol , 
triglycerides , and other lipids to different parts of the body (1) .Hyperlipoproteinemia is a metabolic disorder 
characterized by abnormally elevated concentrations of specific lipoprotein particles in the plasma . 
Hyperlipidemia (i.e. elevated plasma cholesterol or triglyceride levels or both ) is present in all 
hyperlipoproteinemia (2) .  
Adipose tissue is considered as a hormonally active system with metabolic effects. Visfatin is one of the most 
abundant adipocytokines  recently discovered with the capacity to modulate several functions (3, 4) . Visfatin that 
binds to insulin receptor but at a different binding site than insulin itself . The affinities of visfatin and insulin for 
insulin receptors are similar but circulating visfatin concentration is at least  10 times lower than that of insulin . 
The molecular mechanisms revealed that visfatin activates intracellular cascade for insulin signaling , including 
tyrosine phosphorylation of the insulin receptor and insulin receptor as well as downstream activation of protein 
kinase B (5) . The study demonstrated insulin-mimetic effects of visfatin  such as: increased glucose uptake in 
adipocytes and myocytes, suppression of hepatic glucose release, stimulated triglyceride accumulation, and 
increase in its synthesis in pre-adipocytes (6) .  
Competitive inhibition study showed that each of visfatin and insulin compete for the insulin receptor, 
raising the hypothesis that visfatin could have a binding site different from that of insulin. Recombinant 
receptors with structural changes decreasing affinity for insulin didn’t change visfatin binding (7). Increased 
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visfatin levels are associated to coronary artery disease (CAD) and acute coronary syndromes even after 
correction for classic  cardiovascular  risk factors such as cholesterol , smoking , hypertension , diabetes , and  
obesity (8-10)  .  
   The present study aimed to : 
Compare the levels of visfatin  in non-diabetic male with hyperlipidemia and compare it with healthy control . 
Also to find the correlation of visfatin with TC,TG,HDL,LDL, insulin ,HOMA-IR and CRP . 
Material & Methods  
This study included eighty four male with aged ranged (21-50) years and BMI ranged between (19.8-
24.3) Kg/m2. Subjects were divided into four groups group(1) consist of (22) male as healthy control .Patient 
divided into (3) groups according to Fredrecsons classification : 
Group (2) : consist of (20 ) non-diabetic male with hypercholesterolemia[Type I] . 
Group( 3):consist of (20 ) non-diabetic male with hypertriglyceridemia [Type IIa]  . 
Group(4 ): consist of (22) non-diabetic male with hypercholesterolemia and hypertriglyceridemia [Type IIb] . 
The patients attended the Ibn –Al Naphes hospital in Baghdad and Al-Hilla General Teaching Hospital in 
Babylon  for the period from January 2014 to August 2014 .Ten milliliters of blood were collected after an 
overnight fasting from all subjects by venipuncture . A liquate of  (0.5 ml) of whole blood was used in 
determination of HbA1C . The other part was left in 37C˚ for (15 min) to clot then centrifuged at (3000 rpm) for( 
25 min) . The serum which obtained was freezed until analysis of lipid profile , insulin ,CRP and visfatin . 
 
       HbA1C was determined by a bromate affinity assay traceable to the IFCC reference method(11). Total serum 
cholesterol determined by utilizing a kit based on the enzymatic  hydrolysis (12) . The absorbance was recorded 
for the quinonimine (red complex) at 500 nm .The TG determination based on the enzymatic hydrolysis . The 
intensity of the color formed is proportional to the triglycerides concentration in the sample (13) .  
The Chylomicrons and lipoproteins of VLDL, and LDL contained in the serum sample were precipitates. 
HDL levels were determined in the supernatant which obtained after centrifugation according to the based 
method (14)  . 
 LDL-cholesterol and VLDL were estimated indirectly by using  Friedewald formula (15) : 
LDL-c =Total Cholesterol - (HDL-c + VLDL-c) 
VLDL-c(mg⁄dl ) =TG/5 
 Insulin ,CRP and visfatin were determined by using ELIZA teqniech based on the sandwich method (16) 
. HOMA-IR insulin resistance calculated by using the following formula (17) : [fasting glucose × fasting insulin] / 
22.5  .   
All parameters were expressed as(mean  ± SD) .  T-test was used for comparsion among the four studied groups . 
The P-vales < 0.05 and < 0.001 were considered statistically significant and high significant, respectively. 
The Results : 
Analytical parameters : 
The  mean ± SD and T-test of descriptive parameters for non –diabetic  male in the studied groups with 
aged ranged (21-50) years and BMI ranged between(19.8- 24.3) Kg/m2 are presented in table (1) . 
 
Table(1) : Descriptive parameters for all studied groups 
*(S) significant differences , (NS) no significant differences . 
The results in table (1) revealed  no significant elevation in  FBS and HbA1C  levels was found in  
patients groups  when comparing to healthy control  . The results indicate significant elevation in TC and LDL in 
Groups 
 
 
Parameters 
 
G1 
n=22 
G2 
n=20 
G3 
n=20 
G4 
n=22 
T-test 
G1 vs 
G2 
T-test 
G1 vs 
G3 
T-test 
G1 vs 
G4 
T-test 
G2 vs 
G3 
T-test 
G2 vs 
G4 
T-test 
G3 vs 
G4 
HbA1C % 
 
5.04 ± 
0.43 
4.79 ± 
0.37 
4.74 ± 
0.45 
5.0 ± 
0.42 
S NS S S NS S 
TC 
(mg/dl) 
135.36±  
29.88 
223 ± 
10.53 
175 ± 
25.73 
231 ± 
26.75 
NS NS NS NS NS NS 
TG 
(mg/dl) 
109 ± 
17.8 
130 ± 
14.7 
240 ± 
41.7 
302 ± 
87.2 
NS S S S S NS 
HDL 
(mg/dl) 
51.59 ± 
8.8 
43.7 ± 
10.5 
33.5 ± 
5.32 
40.45 ± 
8.36 
S S S NS NS NS 
LDL 
(mg/dl) 
92.2 ± 
25.4 
157.1 ± 
20 
94.32 ± 
31.7 
130.0 ± 
20.2 
S NS S S NS S 
VLDL 
(mg/dl) 
21.8 ± 
7.13 
26.01 ± 
5.84 
48.1 ± 
10.71 
60.5 ± 
14.9 
NS S S S S NS 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.5, No.24, 2015 
 
109 
G2 and G4  comparing to G1. Also , there are significant elevation in G3 comparing to G 2 and  G4 comparing 
to G3,while no significant elevation was found in TC and VLDL in G3 comparing to G1and G4 comparing to 
G2 .The results , also, illustrated significant elevation in TG and VLDL in G3 and G4 when comparing to G1, 
and in G3,G4 comparing to G2 . No significant elevation was noticed in G2 comparing to G1and G4 comparing 
to G3 for TG and HDL . HDL levels showed significant decrease in G2,G4 comparing to G1,while there are 
significant decrease in G3 comparing to G1.  
Elevated TC primarily reflects elevated LDL cholesterol , which constitutes 70% of plasma cholesterol . 
Disorders characterized by elevation of TC alone are classified as Fredrickson type IIa  hyperlipoproteinemia (18 
,19)
 .  
Familial type IIa hypercholesterolemia is a genetic disorder caused by a defect on chromosome 19 .The 
defect makes the body unable to remove low density lipoprotein cholesterol from the blood .This results in high 
levels of LDL in the blood (20, 21) . Type I hyperlipoproteinemia is rare disorder characterized by severe 
elevations in chylomicrons and extremely elevated triglycerides , It is caused by mutations of either the 
lipoprotein lipase gene which is critical for the metabolism of  chylomicrons and VLDL (22) , This condition is 
characterized by inflammation of the pancreas (pancreatitis) (23).An elevated in  TC and decreased in HDL levels 
is observed among hyperinsulinemic and hypertriglyceridemic individuals (24 ,25) . It is proposed that the ability of 
this parameters to predict risk is explained  by the fact that it is a relevant cumulative marker of  the metabolic 
abnormalities found in individuals with high TG-low , HDL-C dyslipidemia  which is a consequence of insulin 
resistance (26) . 
 Table (2) showed ( mean ± SD) and (T-Test) of  insulin , HOMA-IR , visfatin , for all studied groups . 
The results in table (2) showed  a highly significant elevation in insulin and HOMA –IR levels for G2, G3 and 
G4 when comparing to  G1 , while significant elevation  was noticed in G3 and G4  when comparing to  G2 and 
in G4  with G3 .  
 
Table (2) : levels of Insulin , HOMA- IR , visfatin in all studied groups 
 
Groups 
 
Parameters 
G1 
n=22 
G2 
n=20 
G3 
n=20 
G4 
n=22 
T-test 
G1 vs 
G2 
T-test 
G1 vs 
G3 
T-test 
G1 vs 
G4 
T-test 
G2 vs 
G3 
T-test 
G2 vs 
G4 
T-test 
G4 vs 
G3 
Insulin 
(Mu /ml) 
4.88 
±0.4 
8.83 
±1.34 
11.97 
±1.91 
15.98 
±2.91 HS HS HS S S S 
HOMA-IR 
 
18.9 
±3.22 
38.26 
±8.9 
50.11 
±14.4 
65.3 
±15.34 HS HS HS S S S 
CRP 
(mg /dl) 
2.49 
±0.6 
3.54 
±0.4 
3.28 
±0.4 
6.1 
±0.96 S S S NS S S 
Visfatin 
(ng /dl) 
14.85 
±2.3 
21.77 
±2.73 
23.06 
±3.29 
29.76 
±5.27 S S NS NS S S 
* (S)significant differences , (HS) high significant differences ,(NS)No significant differences 
 The HOMA-IR is a condition in which the body ҆s cells become resistance to the effects of insulin . That is 
the normal response to a given amount of insulin is reduced . As a results, higher levels of insulin are needed in 
order for insulin to have its proper effects (27) . The results in table (2) , also , showed significant increase  in CRP  
and visfatin levels for G2 ,G3 and G4 when comparing to G1 and in G4 comparing to G2 and G3, but non- 
significant elevation was found in G3 when comparing to G2 .Levels of visfatin are linked to the CRP  which is 
one of the powerful predictors of atherosclerosis and vascular death (27,28) which in agreement with ours study.  A 
results of the previous investigation  indicate that autocrine effects of visfatin may play an important role in 
regulating insulin sensitivity in the liver. It can be hypothesized that insulin-sensitizing effects of visfatin are 
related to its essential role in the NAD biosynthetic pathway (29) . It was proven that oxidized  LDL  increases the 
visfatin expression in the monocytes cell cultures . More than that, visfatin determines the expression increase of 
some extracellular degrading molecules , causing the instability of the atheroma plaque (30 , 31) .  
 The conclusion could be drown from this study that visfatin increased in  G4 more than other groups 
comparing to G1 . Also, there are significant correlation between visfatin levels with insulin , HOMA-IR and 
CRP levels. 
 As far as to our knowledge this is  the first study determined the levels of  visfatin in young male with 
normal BMI and find its relation with lipid profile in patients with hyperlipoproteinemia which divided 
according to Fredrecsons classification . 
 
Relationships and correlation coefficients : 
Relationship between visfatin viruses, TC,TG,HDL, LDL, insulin , HOMA-IR and CRP were studied for all 
studied groups which shown in table (3) .      
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Table (3) : Correlation coefficient and p-value between visfatin levels and other parameters for all studied 
groups 
     Groups 
 
Parameters 
G1 G2 G3 G4 
r p-value r p-value r p-value r p-value 
(Visfatin) vs    (TC ) 0.0967 S 0.3947 S -0.2317 S 0.343 S 
(Visfatin) vs (TG) 0.0831 HS 0.5051 HS 0.3273 HS 0.146 HS 
(Visfatin) vs (HDL) -0.2824 S -0.0329 S -0.4425 S -0.256 S 
(Visfatin) vs (LDL) 0.0874 S -0.1067 S -0.3132 S 0.096 S 
(Visfatin) vs (insulin) -0.057 S -0.152 S -0.1066 S -0.349 S 
(Visfatin) vs (HOMA-IR) - 0.3146 S -0.0387 S -0.0455 S -0.014 S 
(Visfatin) vs (CRP) -0.181 HS 0.2477 HS -0.4212 HS -0.082 HS 
*(S) Significant differences,(HS) highly significant doifferences,(NS)No significant differences       
 
 A significant positive correlation was found between visfatin levels and (TC) in G1,G2 and G4 (r1 
=0.0967 , r2 = 0.3947 , r4 = 0.3435) respectively , as shown in figure (1 A,B, and D) while significant negative 
correlation was observed in G3    (r3 =-0.2317) between visfatin and (TC) , as shown in figure (1 C) . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A high significant positive correlation coefficients was found between visfatin and TG in four studied groups ( 
r1= 0.08312 , r2 =0.505 , r3 = 0.3278 , r4 =0.1462 ) respectively , as shown in figure (2  A,B,C,D) . 
 
 
 
 
 
Figure (1) Correlation between visfatin and TC in G1(A) , G2 (B) , G3 (C) , G4 (D) 
C 
A B 
D 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.5, No.24, 2015 
 
111 
 
 
 
 
 
 
 
   
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
The result ,also , showed a significant negative correlation between visfatin  levels and HDL for all 
studied groups (r 1= -0.2824, r2 = -0.0329 ,r3= -0.4425 , r4 =-0.2567 ) respectively, as shown in figures (3 A,B,C 
and D) . 
Figure (2)  Correlation between visfatin and TG in  
G1(A),G2(B),G3(C),G4(D) 
A B 
C D 
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The results  in table (3) illustrated significant positive correlation in visfatin levels with LDL in G1 and 
G4 (r1=0.0874 , r4= 0.0967) respectively, as shown in figures (4 A,D),while there are significant negative 
correlation in visfatin levels with LDL in G2 and G3 (r2=-0.1067, r3= -0.313)respectively , as shown in figures (4 
B, C) . 
A B 
C D 
Figure (3)  Correlation between visfatin and HDL in 
G1(A),G2(B),G3(C),G4(D) 
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A significant negative correlation between visfatin and insulin levels in illustrated group (r1=- 0.057, r2= - 
0.152 , r3= - 0.1066 and r4= - 0.349 ) respectively as shown in figures (5  A,B,C,D ) . 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
Figure (4) Correlation between visfatin and LDL in 
G1(A),G2(B),G3(C),G4(D) 
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A significant negative correlation between visfatin and HOMA-IR levels in illustrated group (r1=-0.314, 
r2 = -0.0387, r3 = -0.04559 and r4 = -0.0147) respectively as shown in figures  (6 A, B,C and D ) . 
    
 
 
 
   
 
 
 
 
 
 
A B 
C D 
Figure (5) Correlation between visfatin and insulin in  
G1(A),G2(B),G3(C),G4(D) 
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A highly significant  correlation was found in visfatin and CRP levels in all studied groups which  (r1= 
- 0.1813 , r2 = 0.2477, r3 = - 0.4212  and  r4 = -0.0829) respectively, as shown in figures (7 A ,B ,C and D ) . 
   
   
 
 
 
 
 
 
 
 
 
 
A B 
C D 
Figure (6)Correlation between visfatin and HOMA-IR in 
G1(A),G2(B),G3(C),G4(D) 
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The conclusion could be drown from this study that visfatin increased in  G4 more than other groups 
comparing to G1 . Also, there are significant correlation between visfatin levels with insulin , HOMA-IR and 
CRP levels . As far as to our knowledge this is  the first study determined the levels of visfatin in young male 
with normal BMI and find its relation with lipid profile in patients with hyperlipoproteinemia which divided 
according to Fredrecsons classification . 
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